Do transdermal supplement patches work?

Last updated: October 2026

Drug patches work for a narrow set of molecules: small, fat-loving compounds needed in milligram amounts or less per day, such as nicotine and estradiol. Vitamin and supplement patches lack that evidence. In a 2019 gastric bypass study, 82% of multivitamin patch users had at least one deficiency after a year, against 41% of pill users, and FDA states that dietary supplements must be swallowed.

How does a transdermal patch get anything through the skin?

The main obstacle is the stratum corneum, the skin's outermost layer, which is only 10 to 20 micrometers thick¹. It is built like brick and mortar, with keratin-packed dead cells as bricks and lipid layers as mortar, and a molecule crossing it usually diffuses through those lipids along a winding path around the cells¹.

That structure sets strict entry rules. Drugs that work from a conventional patch have molecular masses of only up to a few hundred daltons, strongly prefer fat over water, and are needed at milligrams per day or less¹. A 2021 review summarizes the same limit: only compounds with suitable lipophilicity and a molecular weight under 500 daltons can be delivered passively through the skin².

When a molecule fits those rules, patches work well. The first transdermal system for systemic delivery, a three-day scopolamine patch for motion sickness, was approved in the United States in 1979, and nicotine patches became the first transdermal blockbuster about a decade later¹. By 2008, FDA-approved systems included estradiol, fentanyl, lidocaine and testosterone, and more than one billion transdermal patches are estimated to be made each year¹. Skin delivery is chosen in particular when the liver would otherwise break down much of a swallowed drug¹.

What does the research show for vitamin and multivitamin patches?

The human evidence is thin and mostly unfavorable. A retrospective study compared 17 gastric bypass patients using a multivitamin patch with 27 using oral supplements for 12 months³. One year after surgery, 82.35% of patch users and 40.74% of pill users had at least one deficiency, vitamin D deficiency affected 81% versus 36%, and the patch group had lower blood levels of vitamin D, vitamin B1 and vitamin B12³.

A 2025 case report describes a woman who developed Wernicke's encephalopathy, a brain disorder that thiamine deficiency can cause, eight months after gastric bypass surgery while using over-the-counter multivitamin patches instead of the prescribed tablets⁴. Her symptoms resolved with supplementation, and the authors concluded that patch supplementation in its current state is questionable and should be avoided⁴.

A 2021 review of transdermal micronutrient patches reached a similar conclusion: the approach looks promising, but limited evidence exists for its efficacy in humans². Limited human data on iron patches point to suboptimal delivery, and laboratory studies of vitamin K, vitamin D and iron patches did not measure blood outcomes².

Do berberine patches work?

Berberine patches are marketed as a way around the compound's poor oral absorption. Berberine (C20H18NO4+), a plant alkaloid, is a cation with a molecular weight of 336.4 and a formal charge of +1⁶. Swallowed, it reaches the blood poorly: in rats, its absolute oral bioavailability was 0.68%⁷.

Its size sits under the 500 dalton threshold^2,6, but size is only one of the conditions. Patch candidates must also be lipid-loving and effective at low amounts¹. Meeting the size rule alone does not show how much berberine reaches the bloodstream.

Regulatory status matters too: a berberine patch sold as a supplement sits outside the US supplement definition, as the next section explains⁵.

Are supplement patches regulated like drug patches?

No. Every system in the list of approved transdermal products is a drug product approved by FDA¹. Under the US definition, a dietary supplement is a product intended for ingestion that contains a dietary ingredient intended to supplement the diet, and FDA spells out that topical or inhaled products are not supplements⁵.

The approved list is short because the first generation of patches depended on selecting drugs that cross the skin at therapeutic rates with little or no enhancement¹. A supplement patch carries no such demonstration, and the human studies that exist found more deficiencies in patch users than in pill users³.

What could make transdermal supplements work in the future?

Delivery science describes three generations of skin delivery¹. The first relies on molecules that already cross skin; the second adds chemical enhancers, iontophoresis or non-cavitational ultrasound, which have struggled to raise delivery across the stratum corneum without damaging deeper tissue¹. The third generation targets the stratum corneum itself with microneedles, thermal ablation, microdermabrasion, electroporation or cavitational ultrasound¹.

Micronutrient research is following that path. In an ex vivo study, vitamin D3 delivered from coated microneedle patches performed about five times better than an ointment with a similar vitamin D3 content². Researchers at King's College London registered a randomized, double-blind, placebo-controlled trial in 2023 to test whether a patch carrying vitamin D phosphate, a more water-soluble vitamin D ester, can improve vitamin D status in up to 100 participants⁸. For now, the review's verdict stands: human evidence for micronutrient patches remains limited².